Naftopidil
Cat.No:IN1800 Solarbio
CAS:57149-07-2
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to off-white Solid
Qty:
Size:
{{cart_num}}
My Cart>
Small Molecule Compounds >
Inhibitors & Antagonists & Agonists >
Endocrinology & Hormones >
NaftopidilCAS:57149-07-2
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to off-white Solid
Qty:
Size:
CAS | 57149-07-2 |
Name | Naftopidil |
Molecular Formula | C24H28N2O3 |
Molecular Weight | 392.49 |
Solubility | Soluble in DMSO(Need ultrasonic) |
Purity | ≥98% |
Appearance | White to off-white Solid |
Storage | Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
MDL | MFCD00242741 |
SMILES | COC1=CC=CC=C1N2CCN(CC2)CC(COC3=CC=CC4=CC=CC=C43)O |
InChIKey | HRRBJVNMSRJFHQ-UHFFFAOYSA-N |
InChI | InChI=1S/C24H28N2O3/c1-28-24-11-5-4-10-22(24)26-15-13-25(14-16-26)17-20(27)18-29-23-12-6-8-19-7-2-3-9-21(19)23/h2-12,20,27H,13-18H2,1H3 |
PubChem CID | 4418 |
Target Point | Adrenergic Receptor |
Passage | Endocrinology & Hormones;GPCR & G Protein;Neuronal Signaling |
Background | It is a selective alpha1- adrenoceptor antagonist. |
Biological Activity | Naftopidil 是一种选择性α1-肾上腺素受体拮抗剂,对克隆的人类α1a-、α1b-和α1d-肾上腺素受体亚型的 Kis 值分别为 3.7 nM、20 nM 和 1.2 nM。Naftopidil 具有抑制细胞增殖的作用。[1-2] |
In Vitro | Naftopidil selectively inhibited the phenylephrine-induced increase in prostatic pressure compared with mean blood pressure in the anesthetized dog model. Naftopidil was selective for the alpha1d-adrenoceptor with approximately 3- and 17-fold higher affinity than for the alpha1a- and alpha1b-adrenoceptor subtypes,respectively.[1] Naftopidil(10 μM; 3 days)showed antiproliferative effects on PCa cells. In PrSC,a strong growth inhibitory effect was observed with naftopidil(0.1-10 μM for PrSC; 3 days). Naftopidil induced G(1)cell-cycle arrest in both PCa cells and PrSC.[2] |
In Vivo | Tumorigenic studies in vivo showed significant reductions in tumor growth when E9 cells(an androgen low-sensitive LNCaP subline)grafted with PrSC were treated with naftopidil(10 mg/kg; p.o; daily; for 28 days).[2] |
Data Literature Source | [1]. Takei R,et al. Naftopidil,a novel alpha1-adrenoceptor antagonist,displays selective inhibition of canine prostatic pressure and high affinity binding to cloned human alpha1-adrenoceptors. Jpn J Pharmacol. 1999 Apr;79(4):447-54. [2]. Hori Y,et al. Naftopidil,a selective {alpha}1-adrenoceptor antagonist,suppresses human prostate tumor growth by altering interactions between tumor cells and stroma. Cancer Prev Res (Phila). 2011 Jan;4(1):87-96. |
Unit | Bottle |
Specification | 250mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.